Aurobindo confident of FDA OK for banned API plant by year end
Aurobindo Pharma is still waiting for US FDA re-approval for its Indian cephalosporin plant, but is confident of a decision by the end of the year.
Archives for October 21, 2012
Octoplus to be stand alone R&D unit says Dr Reddy's; no job cuts planned
Indian drugmaker Dr Reddy’s wants to buy Netherland’s-based formulation services firm Octoplus to expand its drug delivery technology portfolio.
US FTC forces Watson and Actavis to sell to rivals Sandoz and Par
Watson and acquisition target Actavis must sell 18 drugs to rivals Sandoz and Par Pharma under conditions imposed by the US Federal Trade Commission (FTC).
SNBL USA gets animal welfare accreditation
Preclinical services firm SNBL USA has gained AAALAC accreditation for animal research programs at its sites in Everett, Washington and Alice, Texas.
Wuxi opens biologics plant with JV partner AstraZeneca in attendance
Wuxi AppTec has opened a biologics manufacturing facility that will play a key role in its recent accord with Anglo-Swedish drugmaker AstraZeneca.
update - audio available
Catalent says sharing with industry will not dull competetive edge
Catalent says making its technology available to industry will not affect its competitive edge.